2,684
Views
1
CrossRef citations to date
0
Altmetric
Special Section: A Collection of Articles on Opportunities and Challenges in Utilizing Real-World Data for Clinical Trials and Medical Product Development

Comment on “Biostatistical Considerations When Using RWD and RWE in Clinical Studies for Regulatory Purposes: A Landscape Assessment”

ORCID Icon, , ORCID Icon &
Pages 20-22 | Received 01 Aug 2021, Accepted 12 Aug 2021, Published online: 04 Oct 2021
 

Acknowledgments

The authors thank to the research members of AMED Research on Regulatory Science of Pharmaceuticals and Medical Devices.

Additional information

Funding

This work was supported by the Japan Agency for Medical Research and Development (AMED) (grant number JP21mk0101154s0303).